Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

DuPont de Nemours, Inc. DD

Basic Materials — Specialty Chemicals
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index ,
Growth Flags show if company had growth for consecutive years

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
0.61
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — 2 — — — — — — 1 — — —
Insider Ownership
1.01%

Capital & Financial Ratios

Market Cap
17,350.00
Revenue
6,988.00
Net Income
84.00
Free Cash Flow
702.00
Net Debt
1,343.00
Current Ratio
2.43
Debt/Equity
0.23
P/E ratio
286.75
P/S ratio
2.51
P/B ratio
1.26
Past 5Y EPS Growth
20.20%
This Y EPS Growth
43.88%
Next Y EPS Growth
9.79%
Next 5Y EPS Growth
20.01%
in millions of $

Dividends

Payout Ratio
0.68
Annual Dividend Rate
1.44
Annual Dividend Yield
2.25%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 2.41
—
—
—
2025 1.50
—
—
—
—
2024 1.91
—
—
—
—
2023 1.81
—
—
—
—
2022 1.66
—
—
—
—
2021 1.51
—
—
—
—
2020 1.51
—
—
—
—
2019 2.22
—
—
—
—
—
2018 2.72
—
—
—
—
2017 3.72
—
—
—
—
—
—
2016 4.78
—
—
—
—
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 2,803.00 1,798.00 757.00 1,782.00
Receivables 2,370.00 1,342.00 1,669.00 1,751.00
Inventory 2,147.00 1,130.00 1,172.00 1,210.00
Other 194.00 125.00 121.00 113.00
7,514.00 20,775.00 5,575.00 4,856.00
2023 2024 2025 Q'26
Payables 1,675.00 1,054.00 995.00 978.00
ST’ Debt — 1,848.00 60.00 —
Other — — — —
3,098.00 5,496.00 2,305.00 2,001.00
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡ ‡‡‡ ‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 1,681.00 1,819.00 — —
—
’25 1,612.00 1,749.00 3,072.00 416.00
6,849.00
’24 2,931.00 3,171.00 2,862.00 (2,245.00)
6,719.00
’23 3,018.00 3,094.00 3,058.00 (2,556.00)
6,614.00
’22 3,274.00 3,322.00 3,317.00 3,104.00
13,017.00
’21 3,017.00 3,104.00 3,199.00 3,246.00
12,566.00
’20 3,670.00 3,289.00 3,629.00 540.00
11,128.00
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 232.00 400.00 — —
—
’25 77.00 74.00 1,109.00 (700.00)
560.00
’24 493.00 527.00 497.00 (752.00)
765.00
’23 405.00 400.00 740.00 (700.00)
845.00
’22 209.00 277.00 578.00 185.00
1,249.00
’21 378.00 440.00 842.00 186.00
1,846.00
’20 718.00 802.00 1,274.00 1,301.00
4,095.00
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 130.00 324.00 — —
—
’25 (45.00) 24.00 798.00 (550.00)
227.00
’24 291.00 420.00 430.00 (668.00)
473.00
’23 173.00 277.00 637.00 692.00
1,779.00
’22 (27.00) 466.00 487.00 10,612.00
11,538.00
’21 115.00 376.00 747.00 617.00
1,855.00
’20 664.00 564.00 1,652.00 1,054.00
3,934.00
in millions of $

EPS

Mar Jun Sep Dec Year
’26 1.17 1.05 — —
—
’25 (4.23) 0.42 (0.87) (0.90)
(5.58)
’24 1.35 1.26 3.24 (0.84)
5.01
’23 1.68 (0.84) 2.10 (0.15)
2.82
’22 2.85 4.65 2.19 26.07
34.83
’21 26.70 2.70 2.25 1.17
35.67
’20 (2.49) (10.11) (0.33) 0.90
(12.03)

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

1.4
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 62.16 78.83 76.74 67.49 — — —
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 106.90 98.84 113.05 125.55 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 23,000 24,000 24,000 15,000 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.57 0.28 0.28 0.46 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13,017.00 6,614.00 6,719.00 6,849.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 35.45% 32.84% 33.04% 34.50% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,448.00 (279.00) 117.00 200.00 — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11.12% (4.22%) 1.74% 2.92% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5,917.00 462.00 738.00 (738.00) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,135.00 1,248.00 635.00 647.00 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 78.34 44.11 48.09 49.22 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 34.89 2.82 5.04 (5.61) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7.52 5.64 5.48 4.02 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 61.93 6.23 (2.09) (2.39) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 69.44 11.86 3.39 1.63 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 162.61 164.89 170.29 101.35 — — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 166.15 149.95 139.72 139.15 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ 2.41 34.87 18.88 0.00 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.10 2.21 1.99 2.45 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.53 0.59 0.56 1.19 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.34 3.03 2.79 2.81 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.51 11.28 39.63 84.66 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,249.00 845.00 765.00 560.00 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 10,289.00 934.00 (292.00) (333.00) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11,538.00 1,779.00 473.00 227.00 — — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 7,537.00 4,416.00 15,279.00 3,270.00 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8,074.00 7,800.00 7,171.00 3,194.00 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,103.00 4,997.00 5,373.00 2,437.00 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 27,017.00 24,725.00 23,793.00 14,103.00 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13.48% 1.06% 1.87% (2.68%) — — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.87% 0.24% 1.05% 1.96% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 21.71% 1.64% 2.90% (4.11%) — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

DuPont de Nemours (DD) has emerged leaner from its transformative 2017 merger with Dow and 2019 spin-offs, refocusing on high-margin specialties like electronics, water solutions, and safety materials. Revenue has stabilized at $12-13 billion annually through 2024 after a post-restructuring plunge, with impressive efficiency gains—revenue per employee exceeding $500,000 and gross margins holding steady at 35-36%. A fortified balance sheet, featuring an 78% debt reduction to $7.2 billion and consistent positive free cash flow, underscores financial discipline, positioning DD as undervalued with price-to-book ratios around 0.5-0.6x.

However, volatility persists: analysts forecast a stark 45% revenue drop to $6.8 billion in 2025, alongside earnings swings from a projected loss that year to recovery by 2027, amid cyclical end-market risks, insider selling (no buys, $6.3 million in sells), and macroeconomic headwinds like China slowdowns and inflation. While consensus targets suggest 70% upside on EPS rebound and margin resilience, execution risks and underperformance versus the S&P demand caution—ideal for patient investors monitoring the 2025 trough for validation.

Read full commentary →

DuPont de Nemours, Inc. (DD) Latest News

News by impact score

Fine-tune

17 Sep

3 , 6:09 AM
Chemours agreed to a US$455 million PFAS settlement that could reframe its long-term liability narrative, carrying indirect implications for DuPont's own legacy exposure. Chemours PFAS settlement offers a precedent that may influence DuPont's remaining liability management without directly altering its core operations.

16 Sep

3 , 10:29 AM
DuPont expands Tyvek portfolio with lower-carbon material innovation. Lower-carbon Tyvek addition supports product innovation and sustainability positioning without altering core operations or market trajectory.

11 Sep

3 qz.com, 2:07 PM
DuPont, Chemours and Corteva settled North Carolina PFAS claims for $455 million. Large settlement payment resolves PFAS litigation exposure but adds direct financial burden without shifting core operations.

3 www.manufacturingdive.com, 8:30 AM
DuPont, Chemours and Corteva agreed to a $455 million settlement with North Carolina over PFAS contamination claims. The settlement imposes a sizable but shared cash outflow that may trim near-term earnings without altering DuPont's core business trajectory.

10 Sep

3 , 7:00 AM
DuPont, Chemours and Corteva reach agreement to resolve PFAS-related claims in North Carolina. PFAS settlement resolves legal liabilities with moderate financial and operational effects on DuPont.

3 , 6:45 AM
Chemours, DuPont and Corteva reached agreement to resolve PFAS-related claims in North Carolina. Settlement clears major PFAS liabilities for DuPont with direct effects on finances and legal exposure.

29 Aug

4 www.marketbeat.com, 8:01 AM
Qnity Electronics identifies AI and advanced packaging as primary drivers for its next growth phase. AI and advanced packaging focus signals major strategic positioning that can significantly boost DuPont's electronics materials trajectory and investor outlook.

11 Aug

3 transcript www.fool.com, 12:46 PM
DuPont (DD) held Q2 2026 earnings call covering quarterly financial results, segment performance, and forward outlook. Quarterly earnings call supplies updated metrics and guidance that can shift near-term sentiment without altering long-term trajectory.

5 Aug

4 , 5:15 PM
DuPont beat earnings expectations, raised 2026 guidance and launched buybacks, strengthening its financial outlook and market position. Earnings beat, higher long-term guidance and buybacks represent major strategic positives that can materially lift valuation and investor sentiment.

3 , 10:00 AM
DuPont de Nemours Q2 earnings call signals faster growth expected in second half of year. Q2 earnings outlook signals moderately positive trajectory shift for DD without indicating transformative changes.

3 , 4:13 AM
DuPont De Nemours (DD) earnings and guidance reset expectations leaving the stock potentially 20% undervalued. Earnings reset and valuation reset create moderate influence on investor sentiment and near-term stock trajectory.

3 transcript www.marketbeat.com, 1:03 AM
DuPont de Nemours Q2 earnings call highlighted financial results, operational updates and forward guidance. Q2 earnings call delivers financial metrics and guidance that move DuPont's valuation.

4 Aug

4 , 3:01 PM
DuPont de Nemours reports strong Q2 2026 growth across segments and raises full-year guidance on improved demand and operational efficiency. Strong growth and raised guidance directly boost expected revenue, margins, and investor sentiment for DuPont.

4 investorshub.advfn.com, 8:25 AM
DuPont de Nemours exceeded second-quarter expectations and raised its full-year outlook, though shares dipped in premarket trading. Quarterly beat and raised annual guidance point to stronger results and improved prospects ahead.

4 , 6:00 AM
DuPont de Nemours, Inc. reported its second quarter 2026 financial results. Quarterly earnings release reveals core financial performance that directly drives stock valuation and forward guidance.

3 transcript app.moby.co, 5:38 PM
DuPont de Nemours, Inc. presented Q2 2026 earnings results and outlook during its earnings call. Q2 earnings call delivers financial performance details with potential to sway stock movements.

3 , 4:38 PM
DuPont beat quarterly earnings expectations and raised guidance, but its stock gained only marginally as Wall Street showed limited enthusiasm for the results. Beat-and-raise results deliver positive financial signals yet produce only muted stock movement reflecting tempered market expectations.

3 , 9:30 AM
DuPont de Nemours reported Q2 earnings along with analysis of key financial metrics. Q2 earnings data and metrics can moderately shift near-term investor sentiment and stock movement.

29 Jul

3 , 9:09 AM
DuPont de Nemours, Inc. is set to report Q2 earnings, with analysis focused on implications for the stock's near-term performance and investor positioning. Routine quarterly earnings releases deliver financial updates that can shift near-term market views without fundamentally altering long-term company trajectory.

17 Jul

4 , 12:32 AM
DuPont de Nemours launches lithium extraction push, prompting reassessment of DD stock valuation. Lithium extraction push marks major strategic expansion into high-growth battery materials market with potential to reshape revenue trajectory.

16 Jul

4 , 3:12 PM
DuPont de Nemours launches end-to-end direct lithium extraction portfolio targeting battery materials growth and potentially reshaping DD investor positioning. New lithium extraction portfolio marks major strategic entry into high-growth EV battery supply chain.

4 , 10:02 AM
DuPont de Nemours launches end-to-end direct lithium extraction portfolio. New portfolio expands DuPont position in fast-growing lithium extraction market critical for EV batteries.

15 Jul

4 , 9:00 AM
DuPont de Nemours launches end-to-end portfolio to advance direct lithium extraction. Portfolio launch enters DuPont into high-growth lithium extraction sector with potential for major revenue gains.

24 Jun

3 www.cbsnews.com, 12:18 PM
Chemours agrees to pay $450 million in first federal settlement over PFAS forever chemicals contamination from legacy DuPont operations. Chemours PFAS settlement stems directly from DuPont spin-off liabilities that may trigger ongoing financial exposure for DD.

3 PR Newswire, 3:00 AM
DuPont launches Tyvek APX in ASEAN markets. Regional Tyvek product launch may support positioning and sales growth in Asia but does not alter core operations or global trajectory.

12 Jun

4 , 5:08 AM
DuPont de Nemours (DD) stock shows valuation gap after recent pullback amid PFAS litigation risks. PFAS litigation risks can impose major financial liabilities and alter DuPont performance trajectory.

21 May

3 PR Newswire, 9:00 AM
DuPont de Nemours participates in a desalination consortium named semifinalist in the XPRIZE Water Scarcity competition. DuPont's consortium role advances its water technology profile with moderate scope for future positioning gains.

13 May

3 Simply Wall St., 6:40 AM
DuPont de Nemours (NYSE:DD) delivers high-quality earnings backed by low accrual ratios and strong cash conversion, assuring shareholders of sustainable profitability. Validation of earnings quality enhances investor confidence and supports moderate financial performance perception.

12 May

4 Reuters, 9:45 AM
Qnity raised its annual revenue forecast amid climbing AI spending. Qnity's upward revenue revision driven by AI demand surge positions DuPont for significant growth in high-tech materials.

4 Barrons.com, 6:33 AM
DuPont de Nemours (DD) stock rises on strong earnings as semiconductor demand remains robust with no slowdown in sight. Strong earnings and sustained semiconductor demand positively impact DD's financial performance and market trajectory.
© 2016–2026 stockrow.com Terms and Conditions Indicators Weekly Summary Contact Us